Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - COMMON STOCK
Common Stock HALO - Halozyme Therapeutics, Inc.
127 K
LAST VALUE
-4.07%
2 YEAR CAGR
-2.62%
5 YEAR CAGR
1.04%
10 YEAR CAGR